NETEC Announces Ebola Training; Congo Launches Vaccine Campaign

May 21, 2018 - 02:14 PM
NETEC-infectious-disease-workshop

Health care and public health leaders, clinicians and first responders can register to attend an Aug. 7-8 workshop in Atlanta on preparing for Ebola and other emerging infectious diseases, offered by the National Ebola Training and Education Center. NETEC also will offer the two-day workshop later this year in Omaha, NE, and Boston and next year in Denver, Spokane, WA, and Baltimore. For additional Ebola preparedness resources, visit https://netec.org. In other Ebola-related news, the Democratic Republic of Congo has reported 46 Ebola cases and 26 deaths since April, including four confirmed cases in the city of Mbandaka. According to the World Health Organization, the African nation is preparing to offer health workers and other high-risk populations an experimental vaccine that was highly protective against the virus in a large 2015 trial in Guinea. 

Related News Articles

Headline
Study finds steep drop in heart disease death rates
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
White House releases ‘Make America Healthy Again’ report
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
FDA clears first blood test for detecting Alzheimer’s
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…
Headline
NIH finds increase of 14 cancers in people under 50, decreases in others
The National Institutes of Health May 8 released an analysis that found incidences of 14 types of cancer increased among people under age 50 from 2010-2019.…
Headline
Study shows successful use of immunotherapy drug instead of traditional options to treat cancer
A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer…
Headline
Report finds steady decline in cancer death rates
Overall cancer death rates declined steadily among both men and women from 2018 through 2022, according to the National Institutes of Health's latest annual…